Establishing secure connection…Loading editor…Preparing document…

Healthcare Ethical Clearance Letter

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Ethical Clearance Letter

Date:

Issuing Committee

Principal Investigator

Principal Investigator:

Study Information

Clinical trial    Observational study    Retrospective record review    Survey / Interview

Review Details

Committee Review Meeting Date:

Full board review    Expedited review    Exempt determination

Decision and Conditions

Decision of the Committee: Approved    Approved with conditions    Not approved

Obligations of the Principal Investigator

The Principal Investigator must ensure that the research is conducted in accordance with the protocol approved by this Committee and all applicable ethical standards. The Investigator shall comply with the following requirements:

  1. Obtain and retain documented informed consent from each participant when required by the Committee.
  2. Report any serious adverse events, unanticipated problems involving risks to subjects or others, and protocol deviations to the Committee within the timeframes stated below.
  3. Obtain prior approval from the Committee for all amendments that materially alter study design, consent processes, or subject risk.
  4. Maintain secure storage of identifiable data and follow stated data protection measures.

Yes — documented informed consent required    Consent waived or altered as justified to the Committee

Documents Reviewed

The Committee reviewed the following documents and materials as part of its determination:

Protocol / study proposal
Informed consent form(s)
Data collection instruments / questionnaires
Recruitment materials and advertisements
Investigator brochure or equivalent

Certification

By this letter the Ethics Committee certifies that, based on the materials submitted and the review conducted, the study as described has been reviewed for compliance with applicable ethical standards relating to the protection of human subjects. This clearance is granted subject to continued adherence to the approved protocol and the conditions listed above. Failure to comply with conditions, or new information that increases risk to participants, may result in suspension or termination of this clearance.

Committee Contact

Printed Name:

Title:

Signature:

Date:

Enter text✕
Prepare your document for signing right on this page
  • 01 Edit the text and complete the fields
  • 02 Click Sign Now and on the next screen add recipients and signature fields in SignNow
  • 03 Start your free trial to sign and send your doc
Sign Now

What the Healthcare Ethical Clearance Letter Is

A Healthcare Ethical Clearance Letter documents formal approval from an institutional review board (IRB) or ethics committee for human-subjects research, clinical trials, or projects involving protected health information. It confirms that proposed procedures, consent materials, and data handling meet ethical standards and applicable regulations. Institutions, sponsors, and journals commonly require the letter before enrollment, data collection, publication, or grant release. The letter typically identifies the study, principal investigator, protocol number, approved materials, approval date, and any conditions or expiration date tied to continuing review.

Why a Formal Clearance Letter Matters

A Healthcare Ethical Clearance Letter provides documented evidence that a study meets ethical and legal safeguards, supports participant protection, and satisfies institutional, sponsor, and publication requirements.

Why a Formal Clearance Letter Matters

Who Prepares and Receives This Letter

Typical parties involved before and after issuance.

  • Principal Investigator — Submits protocol, answers committee questions, ensures compliance during the study.
  • Research Coordinator — Gathers documents, tracks approvals, and circulates the signed clearance letter to stakeholders.
  • IRB Administrator — Issues the official letter, records conditions, and schedules continuing review.

Recipients usually include sponsors, regulatory offices, clinical sites, and journals requiring proof of ethical oversight.

Core Parts of a Professional Clearance Letter

A clear, consistent format speeds downstream use and reduces questions from sponsors and journals.

Header

Institution name and IRB/committee identifier plus contact details and official letterhead to establish authenticity and traceability.

Study ID

Title, protocol number, study phase, and short protocol synopsis so recipients can immediately confirm the project referenced.

Approved Materials

List of approved documents (consent form, recruitment materials, data collection instruments) including version numbers and dates.

Approval Details

Approval date, expiration or continuing review schedule, and any conditions or special monitoring requirements noted by the committee.

Signatory

Name, role, signature, and date from an authorized IRB official or ethics committee chair validating the decision.

Scope

Geographic sites, participant populations, and any restrictions (age ranges, vulnerable populations, data sharing limits).

Step-by-Step: Preparing and Issuing the Letter

Follow these sequential tasks to prepare a complete clearance letter and minimize review cycles.

  • 01
    Collect Records: Gather protocol, consent, and data protection documents.
  • 02
    Draft Letter: Populate required fields and list approved materials.
  • 03
    IRB Review: Submit draft to IRB for final sign-off and conditions.
  • 04
    Distribute Copy: Send signed letter to sponsor, sites, and records systems.

How the Clearance Letter Flows Through Stakeholders

A predictable routing model helps recipients locate and rely on the document quickly.

  • Origin: IRB office issues official letter on institutional letterhead.
  • Registrar: A copy is recorded in the IRB management system for audit.
  • Sponsor: Sponsor receives the letter to confirm regulatory compliance.
  • Clinical Sites: Sites attach the letter to local regulatory files and study binders.

Digital Workflow Settings Commonly Used for Clearance Letters

Configure a consistent digital workflow so signatures, attachments, and retention are automated and auditable.

Field Configuration
Required Attachments Upload consent, protocol, and data plan
Signer Order IRB chair then compliance officer
Authentication Email link or two-factor for signers
Retention Policy Archive signed letter per institutional schedule

Technical Considerations for eSubmission and Signatures

Choose a platform that supports secure eSign, audit trails, and optional HIPAA-level safeguards.

  • Formats Supported: PDF, DOCX, and XML
  • Integrations: Connects with EHRs and document repositories
  • Authentication Options: Email, SMS, or advanced KBA

Ensure the chosen system supports retention, role-based access, and exportable audit logs for compliance and inspection.

Security and Compliance Elements to Include

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
HIPAA BAA: Use a signed BAA for PHI handling
Audit Trail: Time-stamped signature and IP logging
Access Controls: Role-based access and SSO
Certifications: SOC 2 Type II and ISO 27001 available
Tamper Evidence: Document integrity and change history

Consequences of an Incorrect or Missing Clearance Letter

Regulatory Fines: Potential HIPAA or institutional penalties
Study Suspension: IRB may halt enrollment or data collection
Invalid Approval: Noncompliant letters may be rejected by sponsors
Publication Delay: Journals may refuse manuscripts without proof
Civil Liability: Participant harm can trigger litigation
Data Sharing Barriers: Restricted transfer or secondary use of data

Common Preparation Errors to Avoid

  • Omitting version numbers for consent or protocol documents, creating ambiguity about what was approved.
  • Using inconsistent dates between the letter, protocol, and registry entry, delaying site activation.
  • Failing to include the authorized IRB signatory name and title, which can prompt verification requests.
  • Neglecting to document data protection measures or BAA clauses when PHI is involved.

Typical Timelines and Reporting Deadlines

Schedules vary by IRB type and study complexity; plan submissions and reporting with conservative lead times.

Initial IRB Review:

Usually 4–8 weeks depending on committee workload and study complexity

Continuing Review:

Often required annually unless exempt or granted longer intervals

Unanticipated Event Reporting:

Report serious events per IRB policy, commonly within 5–10 business days

Amendment Review:

Modifications may take 2–6 weeks subject to expedited review

Site Activation:

Sites may require the signed letter before initiating participant enrollment

eSignature Provider Comparison for Clearance Letters

Common provider differences affect cost, HIPAA support, bulk sending, and envelope limits important to institutional workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial Yes, 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
Envelope Cap No cap 100 envelopes/user/year Varies by plan Varies by plan Varies by plan

FAQs: Common Questions About Healthcare Ethical Clearance Letters

Answers to frequent questions about content, signatures, eSubmission, and compliance when using a clearance letter.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users
Sign Now
Company
Forms
Pricing
Resources
Knowledge base
Other Products
© 2026 airSlate Inc. All rights reserved.